Streetbeat News

Products Services

ZVSA

ZyVersa Therapeutics has published an article in a peer-reviewed biomedical journal demonstrating that NLRP3 inflammasome inhibition can reduce symptoms of inflammatory bowel disease in an animal model.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:59 pm

PYR

PyroGenesis has announced successful third-party validation of its fumed silica from lab-scale production. This validation could potentially lead to commercial-scale production.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:45 pm

GOOGL

XMTR

Xometry has announced a contract with Google Cloud to leverage Vertex AI to accelerate the deployment of new auto-quote methods and models.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:38 pm

PHIO

Phio Pharmaceuticals has announced the enrollment of the first US patient in a Phase 1B clinical trial for intratumoral PH-762 Anti-PD-1 therapy for the treatment of skin carcinomas. This marks a significant step in the company's clinical development program.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:33 pm

LILM

Lilium has entered into a partnership with Michelin for the development and serial production of tires for the Lilium Jet. The partnership aims to create custom, sustainable, and high-performance tires for the electric vertical take-off and landing (eVTOL) aircraft.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:33 pm

IKNA

Ikena Oncology has shared initial data from the ongoing dose escalation portion of its Phase 1 trial of IK-930. The data shows signs of clinical activity and tumor shrinkage in multiple patients with difficult-to-treat Epithelioid Hemangioendothelioma.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:31 pm

FCDI

IPSC

Century Therapeutics and Fujifilm Cellular Dynamics have announced a new worldwide license deal and expansion of existing licenses for the development and commercialization of cell therapies for the treatment of autoimmune and inflammatory diseases.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:23 pm

VVV

Valvoline has announced its expectation for FY24 adjusted EPS to be between $1.40-$1.65. The company also plans to add 140-170 stores to its network, with 55-70 of these coming from franchisees.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:19 pm

EVTV

Envirotech Vehicles has launched its first fully electric school bus, named the EVT Bumble Bee.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:43 am